Fangzhou Jianke (06086) expects its annual performance to turn from a loss to a profit.

18:13 25/01/2026

Fangzhou Health (06086) announced that the group expects its revenue for the year 2025 to be approximately RMB 3.5 billion to RMB 3.55 billion, an increase of about 30.0% from the revenue of RMB 2.7074 billion in 2024. The group also expects to achieve a net profit of approximately RMB 7 million to RMB 10 million during the reporting period, a significant turnaround from the pre-tax net loss of RMB 855 million in 2024.

FANGZHOU HEALTH (06086) announced that it expects the group's revenue for the year 2025 to be approximately RMB 3.5 billion to RMB 3.55 billion, an increase of about 30.0% compared to the revenue of RMB 2.7074 billion in 2024. The group also expects to achieve a net profit of approximately RMB 7 million to RMB 10 million during the reporting period, a significant turnaround from the pre-tax net loss of RMB 855 million in 2024. The announcement stated that the expected revenue growth is mainly due to the continuous growth of the company's consumer business division, as the company has attracted more patients and doctors to join the platform. The turnaround to profit is mainly attributed to revenue growth, as well as a decrease in equity-settled transactions based on shares.

BOILLHEALTHCARE (01246) announced its mid-year performance for the 2025 fiscal year. The company's owners' share of the loss amounted to HK$26.972 million, which represents an increase of approximately 2.38 times compared to the same period last year.

RUIHE DATA (03680) plans to privately place up to 158 million shares with a net fundraising of approximately 1.23 billion Hong Kong dollars.

Yum China (09987) repurchased approximately 81,400 shares on January 23rd.

RUIHE DATA (03680) plans to privately place up to 158 million shares with a net fundraising of approximately 1.23 billion Hong Kong dollars.

Yum China (09987) repurchased approximately 81,400 shares on January 23rd.